Medscape Medical News - FDA Approvals
- Alert FDA Updates Labels for Two Cholesterol-Lowering Agents
- Alert FDA OKs Enfortumab Vedotin Plus Pembro for Urothelial Cancer
- Alert FDA Approves Tralokinumab for Treating Eczema in Adolescents
- Alert FDA Approves Implant for Glaucoma
- Belzutifan Approved for Advanced Renal Cell Carcinoma
- Alert FDA Approves First Pulsed Field Ablation System for AF
- Alert Antiparasitic Wins FDA Approval for High-Risk Neuroblastoma
- Alert FDA OKs Two Gene-Editing Therapies for Sickle Cell Disease
- Alert FDA OKs Iptacopan to Treat Paroxysmal Nocturnal Hemoglobinuria
- Alert FDA Approves Pirtobrutinib for Previously Treated CLL/SLL
- Alert FDA Investigates Secondary Cancers From CAR T-Cell Therapies
- Alert FDA OKs New Agent to Block Chemotherapy-Induced Neutropenia
- Alert FDA Approves Nirogacestat for Desmoid Tumors
- Alert FDA OKs Symplicity Renal Denervation System for Hypertension
- Alert FDA Expands Enzalutamide Approval to Earlier Prostate Cancer
- Alert FDA OKs First-Line Pembro With Chemo for Gastric/GEJ Cancer
- Alert FDA OKs Capivasertib for Certain Advanced Breast Cancers
- Alert FDA Approves Repotrectinib for ROS1-Positive NSCLC
- Alert FDA Approves First Drug for Rare, Deadly Clotting Disorder
- FDA Amends Pembrolizumab Indication in Gastric Cancer
- Alert FDA Approves Fruquintinib for Metastatic Colorectal Cancer
- FDA OKs Paradise Renal Denervation System for Hypertension
- Alert FDA OKs New Treatment for Erosive Esophagitis
- Alert FDA Approves First Ustekinumab Biosimilar
- FDA Approves Abatacept for Pediatric Patients With Psoriatic Arthritis
- Alert FDA Approves Toripalimab for Nasopharyngeal Carcinoma
- Alert FDA Clears First OTC Fentanyl Urine Test
- Alert FDA Approves Mirikizumab for Ulcerative Colitis
- Alert FDA Okays Drug for Duchenne Muscular Dystrophy
- Alert FDA OKs Ivosidenib for IDH1-mutated Myelodysplastic Syndromes